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CD5 is constitutively expressed on T cells and a subset of mature normal and
leukemic B cells in patients with chronic lymphocytic leukemia (CLL). Important
functional properties are associated with CD5 expression in B cells, including signal
transducer and activator of transcription 3 activation, IL-10 production and the
promotion of B-lymphocyte survival and transformation. However, the pathway(s) by
which CD5 influences the biology of B cells and its dependence on B-cell receptor
(BCR) co-signaling remain unknown. In this study, we show that CD5 expression
activates a number of important signaling pathways, including Erk1/2, leading to
IL-10 production through a novel pathway independent of BCR engagement. This
pathway is dependent on extracellular calcium (Ca) entry facilitated by upregulation
of the transient receptor potential channel 1 (TRPC1) protein. We also show that
Erk1/2 activation in a subgroup of CLL patients is associated with TRPC1
overexpression. In this subgroup of CLL patients, small inhibitory RNA (siRNA) for
CD5 reduces TRPC1 expression. Furthermore, siRNAs for CD5 or for TRPC1 inhibit
IL-10 production. These findings provide new insights into the role of CD5 in B-cell
biology in health and disease and could pave the way for new treatment strategies
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